High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy

Autor: Chen, Zhuo-Kun, Zheng, Shuo, Long, Yan, Wang, Kui-Ming, Xiao, Bo-Lin, Li, Jin-Bang, Zhang, Wei, Song, Heng, Chen, Gang
Zdroj: In Molecular Therapy 2 October 2024 32(10):3580-3596
Databáze: ScienceDirect